Treatment outcomes for childhood acute lymphoblastic leukemia in low-middle income country before minimal residual disease risk stratification
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Cancer Epidemiology
- Vol. 75, 102040
Abstract
No abstract availableKeywords
Funding Information
- Ain Shams University
This publication has 24 references indexed in Scilit:
- Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology GroupBlood, 2011
- Outcome of childhood acute lymphoblastic leukemia in JordanPediatric Blood & Cancer, 2011
- Treating Childhood Acute Lymphoblastic Leukemia without Cranial IrradiationNew England Journal of Medicine, 2009
- Treatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low‐income countries: A proposalPediatric Blood & Cancer, 2009
- Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology GroupBlood, 2008
- High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemiaBlood, 2008
- Treatment of Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2006
- Intensification of Therapy for Children With Lower-Risk Acute Lymphoblastic Leukemia: Long-Term Follow-Up of Patients Treated on Children’s Cancer Group Trial 1881Journal of Clinical Oncology, 2003
- Acute Lymphoblastic Leukemia in a Developing Country: Preliminary Results of a Nonrandomized Clinical Trial in El SalvadorJournal of Pediatric Hematology/Oncology, 2000
- Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodThe Lancet, 1998